Microsoft PowerPoint - AVNT Q2 2022 Earnings Presentation AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 2 R E S U L T S (NYSE: AVNT) J U LY 2 6 , 2 0 2 2 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Defense 6% END MARKET TRANSFORMATION TO LESS CYCLICAL INDUSTRIES ( W IT H DY N E E MA, E X . Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% Latin America 2021 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% Building and END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) 24 34% Building & 1% Telecommunications C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILL ION 32% 40% Latin America END MARKET REGION 25 S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 27% Building & 2021 REVENUE | $919 MILLION END MARKET 55% REGION 26 D I S T R I BU T I O N 26% Building and 80% 3% Latin America END MARKET REGION K E Y S U P P L I ER S 2021 REVENUE | $1 .6 B ILL ION 27 TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET 30% 26%Healthcare 14% Building & 2% Energy (16% of sales) 32% Building & (25% of sales) 28 19% Building & US & Canada (50% of sales) 38% 33% Building & LATAM (9% of sales) Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Avient corporation first quarter 2024 results and 2024 financial guidance AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) M AY 7 , 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 O P E N I N G RE MARK S 4 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 4 +2% -6% Flat +2% Avient ex. Q1 2023 (TOTAL COMPANY) $846 $829 $134 $143 17.3% (in millions) $0.63 $0.76 Adjusted EPS (in millions) + 7% + 21% Sales Adjusted EBITDA Adjusted EPS 6 - 2% 15.8% +150 bps Q1 2024 SEGMENT PERFORMANCE (COLORS, ADDITIVES & INKS) $537 $515 $91 $97 18.8% (in millions) (in millions) + 7% 7 - 4% 17.0% +180 bps • Year over year demand continues to improve for the segment but slowly due to continued weakness in Europe • Raw material deflation & cost reduction actions primary drivers of adjusted EBITDA growth and margin expansion of +180 bps vs Q1 2023 Q1 2024 SEGMENT PERFORMANCE (SPECIALTY ENGINEERED MATERIALS) $310 $314 $64 $73 23.2% (in millions) (in millions) + 14% 8 + 1% 20.8% +240 bps • Sales growth in defense end market offset by weaker demand in telecommunications end market • Raw material deflation and favorable mix impact from defense sales primary drivers of adjusted EBITDA growth and margin expansion of +240 bps vs Q1 2023 Q1 EBITDA BRIDGE (TOTAL COMPANY) 9 $ millions CAI: Price / Mix (1) Deflation 16 SEM: Price / Mix 4 Deflation 7 Net Price Benefit 26 Wage/Other Inflation (9) FX (2) Q1 2024 $143 Adjusted EBITDA Q1 2023 $ 134 Demand (6) • Positive net price benefit: o Favorable raw material deflation in both segments • Wage and other inflation more than offset cost reductions/synergies 2024 G U I DAN CE FY 2024 GUIDANCE Original Revised Adjusted EBITDA $505 to $535 million $510 to $535 million Adjusted EPS $2.40 to $2.65 $2.50 to $2.65 Interest Expense $105 to $110 million $105 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures ~$140 million ~$140 million 11 Q2 2024: Adjusted EPS of $0.71 CE O “ TO P O F MI N D” FO CU S ARE AS AREAS OF FOCUS 13 +7% Drive Profitable Organic Top-Line Growth with Margin Expansion Amplify Innovation Build Leadership & Talent Pipeline AP P E N DI X 16 Performance Additives 15% Pigments TiO2 Dyestuffs Polyethylene 10%Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% 36% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% 23%Industrial Building and 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) 7% 18 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 BILLION 34% 37% 21% END MARKET REGION 19 34% 21% 15% Building & 1% Energy COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 BILLION 52% 35% 20 6%Industrial 12% 10% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 26% Building & 6% 2% Defense 1% (18% of sales) 2023 AVIENT REGIONAL SALES 25% Building & (36% of sales)Transportation 22% Building & 12% 6% US & Canada (41% of sales) 59% 22% Building & LATAM (5% of sales) 21 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

KEY CHARACTERISTICS ECCOH 5924 ECCOH 5981 ECCOH 5983 UV Material Standards BS7655-6, 1 (LTS1–4), BS6724, IEC 60502 BS7655-6, 1 (LTS3) BS7655-6, 1 (LTS1–4) Tear Strength at 23°C 7.7 N/mm 10 N/mm 11 N/mm Tear Strength at 65°C 2.3 N/mm 5 N/mm 6.5 N/mm Hot Pressure Test (6h at 90°C) 39% –

lang=En&n=3C401D5C-1 http://www.ec.gc.ca/default.asp? lang=En&n=BD3CE17D-1 http://www.ec.gc.ca/default.asp? n=29E6BF9F-1&lang=en http://www.ec.gc.ca/default.asp?

UTG® HUNTING & SHOOTING SPORTS G U N M A G A Z I N E H O U S I N G • Good dimension stability with low warpage at different temperature ranges (70˚C, room temperature, -40˚C) • Good appearance with less glass fiber exposure • Provided durable and impact-resistant glass fiber reinforced formulation with excellent surface finish and good dimensional stability for smooth operation • Passed all temperature durability and drop tests to confirm use in outdoor environments • Collaborated with customer via technology services to accelerate product development Bergamid™ Customized Polyamide Formulation KEY REQUIREMENTS WHY AVIENT?

ANTENNA MANUFACTURER P H A S E S H I F T A N T E N N A • Achieved miniaturization through customized high dielectric constant (Dk) materials • Offered high Dk grades with superior processing window and stability compared to lower Dk ( < Dk6.0) grades • Verified dimensional and electrical stability would also meet needs of navigation system substrate to streamline sourcing Edgetek™ Formulations for 5G KEY REQUIREMENTS WHY AVIENT?

SURGICAL INSTRUMENT OEM I N T R A O R A L S C A N N E R • Chemical and impact resistance • Customized pre-colored solutions • Color and dimension stable after sterilization • Minimum color deviation and easy to process • Technical support and color expertise • Offered bright white and customized pre- colored formulations in PPSU and PSU for intraoral scanner head and body parts • Provided a solution that can withstand up to 1,000 cycles autoclave, with good chemical and excellent impact resistance • Met customer request for color stability after processing and biocompatible compliance Transcend™ Premier Healthcare Colorants KEY REQUIREMENTS WHY AVIENT?

Surgical instrument oem SURGICAL INSTRUMENT OEM E N D O S C O P E C O M P O N E N T S • Functional differentiation • ISO 10993 compliance • Excellent resistance to steam sterilization • Excellent chemical resistance • Delivered a variety of bright, distinguishing color choices for functional differentiation • Minimized color deviation • Provided a biocompatible solution • Offered low MOQ with flexible supply Transcend Premier PPSU Healthcare Pre- colored Solutions KEY REQUIREMENTS WHY AVIENT?

DENTAL TOOL OEM 3 D D E N T A L S C A N N E R • Achieve accurate color match to non-polysulfone (PSU) components • Must be compatible with hospital disinfectants and survive repeated steam sterilization • Developed precise color match to other resins used in adjacent parts, maintaining accurate brand identification • Provided expertise in pigments and critical color manufacturing for high performance resins • Customized a high-performance solution able to withstand steam sterilization in an autoclave Transcend™ Precolored Gray and Precolored White PSU KEY REQUIREMENTS WHY AVIENT?

Trilliant XR - CT and MRI Scanners MEDICAL DEVICE MANUFACTURER M R I A N D C T S C A N N E R S • Uniform shielding with no “hot spots” • X-ray shielding up to 140 KeV • Meet European Union’s Restriction of Hazardous Substances (RoHS) future compliance requirements • Provided a lead alternative solution that delivered improved geometric flexibility for more uniform radiation shielding • Lowered shielding component costs 30-50% by eliminating machining and assembly steps Trilliant™ XR Lead Replacement Thermoplastics KEY REQUIREMENTS WHY AVIENT?